Your career starts on Magnet.me
Create a profile and receive smart job recommendations based on your liked jobs.
Are you interested in developing new mass spectrometry-based workflows in proteomics and immunopeptidomics? At Utrecht University, we are building an expert team to improve technologies that identify disease-related peptides and advance immunotherapy research. Join us in pushing the boundaries of MS-based analysis.
Our team studies peptides presented on Human Leukocyte Antigen (HLA) complexes on the surface of cells, which are recognised by the immune system. These peptides can trigger targeted immune responses to clear infections and tumors or contribute to autoimmune diseases. Identifying disease-driving HLA-bound peptides is crucial for selecting novel targets for immunotherapies.
This project focuses on developing highly sensitive and alternative immunopeptidomics/proteomics workflows, including sample preparation, chromatography, mass spectrometry acquisition, fragmentation, and data analysis. The goal is to enhance the detection of HLA class I and II peptides, both with and without post-translational modifications. Additionally, the project aims to optimise biochemical and bioinformatic quantitative strategies to improve the selection of HLA-bound tumour-specific antigens. You will also collaborate with laboratories within Oncode and the Princess Máxima Institute.
Your main tasks are:
You possess multiple of the following qualifications:
We work on a better future. In order to do that, we join forces with academics, students, alumni, social partners, the government and the corporate world. Together, we look for sustainable solutions to the big challenges of today and tomorrow.
Change language to: Dutch
This page is optimised for people from the Netherlands. View the version optimised for people from the UK.